+91 789 2456 581 | info@nckpharma.com

Pharma News

Keep updating your pharma knowledge
28 Mar 2016

Zydus buys gastro therapy brand, Actibile from Albert David

Cadila Healthcare Limited has entered into a definitive agreement to acquire ‘Actibile’ from Albert David Limited (ADL).  The brand falls in the gastroenterology segment and is used for dissolving gall bladder stones. The deal will be financed through internal accruals
The gastrointestinal segment has been one of our core focus segment of Zydus. This acquisition will strengthen Zydus Gastro portfolio of brands and leverage our equity in gastro segment.
Actibile contains Ursodeoxycholic Acid

Ursodiol, also known as ursodeoxycholic acid and the abbreviation UDCA, is one of the secondary bile acids, which are metabolic byproducts of intestinal bacteria.

Leave a Reply

Scale up your Pharma knwledge to Next Level with our Free Content

Case studies & Caselets
Simulation based learning
Online self competency assessment tests 

etc.